Docebo Inc
NASDAQ:DCBO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
34.39
54.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Docebo Inc
Wall Street
Price Targets
DCBO Price Targets Summary
Docebo Inc
According to Wall Street analysts, the average 1-year price target for
DCBO
is 39.7 USD
with a low forecast of 32.19 USD and a high forecast of 45.74 USD.
DCBO Last Price Targets
Docebo Inc
The latest public price target was made on Oct 24, 2024 by
Kevin Krishnaratne
from
Scotiabank
,
who expects
DCBO
stock to
rise by 9%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Kevin Krishnaratne
Scotiabank
|
55
USD
Upside 9% |
2 weeks ago
Oct 24, 2024
|
Docebo Inc. (DCBO) PT Raised to $55 at Scotiabank
StreetInsider
|
Kevin Kumar
Goldman Sachs
|
48
USD
Downside 5% |
1 month ago
Sep 16, 2024
|
Goldman Sachs Reiterates Neutral Rating on Docebo Inc. (DCBO)
StreetInsider
|
Ryan MacDonald
Needham
|
50
USD
Downside 1% |
2 months ago
Sep 12, 2024
|
Docebo Inc. (DCBO) PT Raised to $50 at Needham
StreetInsider
|
Robert Young
Canaccord Genuity
|
54
USD
Upside 7% |
3 months ago
Aug 9, 2024
|
Docebo Inc. (DCBO) PT Lowered to $54 at Canaccord Genuity
StreetInsider
|
|
George Sutton
Craig-Hallum
|
58
USD
Upside 14% |
5 months ago
Jun 7, 2024
|
Docebo initiated with a Buy at Craig-Hallum
TheFly
|
|
Kevin Krishnaratne
Scotiabank
|
50
USD
Downside 1% |
5 months ago
May 14, 2024
|
Docebo Inc. (DCBO) PT Lowered to $50 at Scotiabank
StreetInsider
|
|
Robert Young
Canaccord Genuity
|
55
USD
Upside 9% |
5 months ago
May 14, 2024
|
Docebo Inc. (DCBO) PT Lowered to $55 at Canaccord Genuity
StreetInsider
|
|
Ryan MacDonald
Needham
|
56
USD
Upside 11% |
11 months ago
Nov 14, 2023
|
Docebo Poised To Deliver A Balanced Mix Of Growth & Profitability In FY24: Analyst
Benzinga
|
Josh Baer
Morgan Stanley
|
49
USD
Downside 3% |
1 year ago
Aug 18, 2023
|
Morgan Stanley Upgrades Docebo Inc. (DCBO) to Overweight
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DCBO's stock price target?
Price Target
39.7
USD
According to Wall Street analysts, the average 1-year price target for
DCBO
is 39.7 USD
with a low forecast of 32.19 USD and a high forecast of 45.74 USD.
What is Docebo Inc's Revenue forecast?
Projected CAGR
17%
For the last 6 years the
compound annual growth rate for
Docebo Inc's revenue is
48%.
The projected
CAGR
for the next 3 years is
17%.
What is Docebo Inc's Operating Income forecast?
Projected CAGR
309%
The
compound annual growth rate
of Docebo Inc's operating income for the next 3 years is
309%.
What is Docebo Inc's Net Income forecast?
Projected CAGR
135%
The
compound annual growth rate
of Docebo Inc's net income for the next 3 years is
135%.
You don't have any saved screeners yet
